You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapies

  • Technology appraisal guidance
  • Reference number: TA171
  • Published:  18 June 2009
  • Last updated:  26 June 2019
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Information for the public

  • Lenalidomide for multiple myeloma in people who have had previous treatment (PDF 150 KB)

    Published:
    18 June 2009
  • Gwybodaeth i'r cyhoedd (Word 241 KB)

    Published:
    16 November 2009
Back to top